Walvax BioTech (300142) — Financial Flexibility Index
Walvax BioTech (300142) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥182.25 Million (operating CF CN¥-33.52 Million minus capex CN¥215.77 Million) represents 0% of total liabilities (CN¥2.31 Billion). Check 300142 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Walvax BioTech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Walvax BioTech across 19 annual periods. See Walvax BioTech short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Walvax BioTech (2007–2025)
Year-by-year free cash flow to debt coverage for Walvax BioTech. For the full company profile including market capitalisation, see Walvax BioTech market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥1.00 Billion | CN¥494.37 Million | CN¥2.26 Billion | ▼ -9.8% |
| 2024 | 0.49x | CN¥1.59 Billion | CN¥1.04 Billion | CN¥3.22 Billion | ▼ -0.5% |
| 2023 | 0.50x | CN¥2.08 Billion | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -6.0% |
| 2022 | 0.53x | CN¥2.29 Billion | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +7.2% |
| 2021 | 0.49x | CN¥1.81 Billion | CN¥705.28 Million | CN¥3.68 Billion | ▲ +69.9% |
| 2020 | 0.29x | CN¥521.32 Million | CN¥114.19 Million | CN¥1.80 Billion | ▼ -5.4% |
| 2019 | 0.31x | CN¥413.84 Million | CN¥62.02 Million | CN¥1.35 Billion | ▲ +274.5% |
| 2018 | 0.08x | CN¥162.09 Million | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -40.9% |
| 2017 | 0.14x | CN¥320.93 Million | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +141.8% |
| 2016 | 0.06x | CN¥160.30 Million | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -5.2% |
| 2015 | 0.06x | CN¥195.34 Million | CN¥-69.41 Million | CN¥3.23 Billion | ▼ -4.6% |
| 2014 | 0.06x | CN¥174.46 Million | CN¥-65.93 Million | CN¥2.76 Billion | ▼ -24.5% |
| 2013 | 0.08x | CN¥267.94 Million | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -75.3% |
| 2012 | 0.34x | CN¥434.25 Million | CN¥78.38 Million | CN¥1.28 Billion | ▼ -65.6% |
| 2011 | 0.99x | CN¥289.54 Million | CN¥91.98 Million | CN¥293.62 Million | ▲ +70.7% |
| 2010 | 0.58x | CN¥251.53 Million | CN¥86.71 Million | CN¥435.52 Million | ▼ -22.2% |
| 2009 | 0.74x | CN¥156.94 Million | CN¥82.18 Million | CN¥211.43 Million | ▲ +537.6% |
| 2008 | 0.12x | CN¥23.70 Million | CN¥-5.69 Million | CN¥203.54 Million | ▼ -53.6% |
| 2007 | 0.25x | CN¥50.10 Million | CN¥31.85 Million | CN¥199.86 Million | — |